Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
- PMID: 8523565
- PMCID: PMC189840
- DOI: 10.1128/JVI.70.1.520-532.1996
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
Abstract
Adeno-associated virus is an integrating DNA parvovirus with the potential to be an important vehicle for somatic gene therapy. A potential barrier, however, is the low transduction efficiencies of recombinant adeno-associated virus (rAAV) vectors. We show in this report that adenovirus dramatically enhances rAAV transduction in vitro in a way that is dependent on expression of early region 1 and 4 (E1 and E4, respectively) genes and directly proportional to the appearance of double-stranded replicative forms of the rAAV genome. Expression of the open reading frame 6 protein from E4 in the absence of E1 accomplished a similar but attenuated effect. The helper activity of adenovirus E1 and E4 for rAAV gene transfer was similarly demonstrated in vivo by using murine models of liver- and lung-directed gene therapy. Our data indicate that conversion of a single-stranded rAAV genome to a duplex intermediate limits transduction and usefulness for gene therapy.
Similar articles
-
The adenovirus E4 ORF6 and E1b 55 kDa proteins cooperate in a p53-independent manner to enhance transduction by recombinant adeno-associated virus vectors.J Gen Virol. 2000 Dec;81(Pt 12):2983-2991. doi: 10.1099/0022-1317-81-12-2983. J Gen Virol. 2000. PMID: 11086129
-
Overexpression of cyclin A inhibits augmentation of recombinant adeno-associated virus transduction by the adenovirus E4orf6 protein.J Virol. 1999 Dec;73(12):10010-9. doi: 10.1128/JVI.73.12.10010-10019.1999. J Virol. 1999. PMID: 10559315 Free PMC article.
-
Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction.Hum Gene Ther. 1999 Mar 1;10(4):591-602. doi: 10.1089/10430349950018661. Hum Gene Ther. 1999. PMID: 10094202
-
Adenovirus-adeno-associated virus hybrid for large-scale recombinant adeno-associated virus production.Hum Gene Ther. 2009 Sep;20(9):922-9. doi: 10.1089/hum.2009.125. Hum Gene Ther. 2009. PMID: 19618999 Review.
-
Cell transformation by the adenovirus oncogenes E1 and E4.FEBS Lett. 2020 Jun;594(12):1848-1860. doi: 10.1002/1873-3468.13717. Epub 2019 Dec 20. FEBS Lett. 2020. PMID: 31821536 Review.
Cited by
-
Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteins.Mol Ther. 2012 Nov;20(11):2087-97. doi: 10.1038/mt.2012.144. Epub 2012 Jul 31. Mol Ther. 2012. PMID: 22850678 Free PMC article.
-
Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia.J Genet Syndr Gene Ther. 2012 Jan 18;1:1-9. doi: 10.4172/2157-7412.S1-009. J Genet Syndr Gene Ther. 2012. PMID: 23565343 Free PMC article.
-
Development of Novel Recombinant AAV Vectors and Strategies for the Potential Gene Therapy of Hemophilia.J Genet Syndr Gene Ther. 2012 Jan 10;S1:008. doi: 10.4172/2157-7412.S1-008. J Genet Syndr Gene Ther. 2012. PMID: 23264889 Free PMC article.
-
Gene Therapy in Retinal Dystrophies.Int J Mol Sci. 2019 Nov 14;20(22):5722. doi: 10.3390/ijms20225722. Int J Mol Sci. 2019. PMID: 31739639 Free PMC article. Review.
-
Adeno-associated virus vectors: potential applications for cancer gene therapy.Cancer Gene Ther. 2005 Dec;12(12):913-25. doi: 10.1038/sj.cgt.7700876. Cancer Gene Ther. 2005. PMID: 15962012 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical